Stokes & Hubbell Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $4.11M | Sell |
102,048
-1,914
| -2% | -$77.1K | 0.86% | 34 |
|
2018
Q4 | $4.31M | Sell |
103,962
-196
| -0.2% | -$8.12K | 0.98% | 29 |
|
2018
Q3 | $4.36M | Buy |
104,158
+1,413
| +1% | +$59.1K | 0.9% | 33 |
|
2018
Q2 | $3.54M | Buy |
102,745
+2,299
| +2% | +$79.1K | 0.8% | 36 |
|
2018
Q1 | $3.38M | Buy |
100,446
+6,703
| +7% | +$226K | 0.78% | 35 |
|
2017
Q4 | $3.22M | Sell |
93,743
-212
| -0.2% | -$7.28K | 0.78% | 35 |
|
2017
Q3 | $3.18M | Buy |
93,955
+36,985
| +65% | +$1.25M | 0.82% | 33 |
|
2017
Q2 | $1.82M | Sell |
56,970
-559
| -1% | -$17.8K | 0.56% | 44 |
|
2017
Q1 | $1.87M | Buy |
57,529
+2,068
| +4% | +$67.1K | 0.63% | 41 |
|
2016
Q4 | $1.71M | Buy |
55,461
+37
| +0.1% | +$1.14K | 0.66% | 38 |
|
2016
Q3 | $1.78M | Buy |
55,424
+3,490
| +7% | +$112K | 0.74% | 36 |
|
2016
Q2 | $1.74M | Buy |
51,934
+7,103
| +16% | +$237K | 0.75% | 35 |
|
2016
Q1 | $1.26M | Buy |
44,831
+21,678
| +94% | +$610K | 0.58% | 38 |
|
2015
Q4 | $709K | Sell |
23,153
-263
| -1% | -$8.05K | 0.38% | 45 |
|
2015
Q3 | $698K | Buy |
+23,416
| New | +$698K | 0.42% | 44 |
|